Hemostemix Announces Corporate Update
February 28, 2020 18:28 ET
|
Hemostemix Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”)...
Hemostemix Announces Corporate Update
February 27, 2020 09:15 ET
|
Hemostemix Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...
Hemostemix Announces Corporate Update
February 25, 2020 09:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) provides the following update: On February 21, 2020, the Court Queen’s...
Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000
February 19, 2020 20:00 ET
|
Hemostemix Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...
Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update
February 10, 2020 09:03 ET
|
Hemostemix Inc.
CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce the appointment of Dr. Ronnie Hershman, M.D.,...
Hemostemix Provides Corporate Update and Clarification
January 26, 2020 23:00 ET
|
Hemostemix Inc.
CALGARY, Alberta, Jan. 26, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) provides the following corporate update and clarification of previous...
Hemostemix Announces Private Placement
January 02, 2020 08:30 ET
|
Hemostemix Inc.
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
Hemostemix Announces Corporate Update
December 11, 2019 07:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTC: HMTXF) is pleased to announce the appointment of David Wood to the...
Hemostemix Announces Appointment of Director and Postponement of Annual and Special Meeting
December 02, 2019 22:37 ET
|
Hemostemix Inc.
CALGARY, Alberta, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTC: HMTXF), a biotechnology company focused on developing and commercializing...
Hemostemix Announces Appointment of Director
November 29, 2019 14:04 ET
|
Hemostemix Inc.
CALGARY, Alberta, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and...